Innovative drug synthesis / (Record no. 19441)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02855cam a2200613 i 4500 |
001 - CONTROL NUMBER | |
control field | ocn911618038 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20230823095527.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION | |
fixed length control field | m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr ||||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 150623s2015 nju ob 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER | |
LC control number | 2015025120 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | DLC |
Language of cataloging | eng |
Description conventions | rda |
Transcribing agency | DLC |
Modifying agency | OCLCF |
-- | N$T |
-- | IDEBK |
-- | DG1 |
-- | CDX |
-- | COO |
-- | YDXCP |
-- | DEBBG |
-- | RECBK |
019 ## - | |
-- | 931157870 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 9781118820025 (pdf) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 1118820029 (pdf) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 9781118820087 (epub) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 1118820088 (epub) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Cancelled/invalid ISBN | 9781118820056 (cloth) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 9781118819951 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 1118819950 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 1118820053 (cloth) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 9781118820056 (cloth) |
029 1# - (OCLC) | |
OCLC library identifier | GBVCP |
System control number | 845212419 |
029 1# - (OCLC) | |
OCLC library identifier | DEBBG |
System control number | BV043738005 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)911618038 |
Canceled/invalid control number | (OCoLC)931157870 |
042 ## - AUTHENTICATION CODE | |
Authentication code | pcc |
050 00 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RS420 |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MED |
Subject category code subdivision | 071000 |
Source | bisacsh |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 615.1/9 |
Edition number | 23 |
049 ## - LOCAL HOLDINGS (OCLC) | |
Holding library | MAIN |
245 00 - TITLE STATEMENT | |
Title | Innovative drug synthesis / |
Statement of responsibility, etc | edited by Jie Jack Li, Douglas S. Johnson. |
264 #1 - | |
-- | Hoboken, New Jersey : |
-- | Wiley, |
-- | 2015. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource. |
336 ## - | |
-- | text |
-- | rdacontent |
337 ## - | |
-- | computer |
-- | rdamedia |
338 ## - | |
-- | online resource |
-- | rdacarrier |
490 0# - SERIES STATEMENT | |
Series statement | Drug synthesis series |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc | Includes bibliographical references and index. |
588 ## - | |
-- | Description based on print version record and CIP data provided by publisher. |
520 ## - SUMMARY, ETC. | |
Summary, etc | This book covers all aspects of the medicinal chemistry of the latest drugs, and the cutting-edge science associated with them. Following the editors' 3 successful drug synthesis books, this provides expert analysis of the pros and cons of different synthetic routes and demystifies the process of modern drug discovery for practitioners and researchers. -Summarizes for each drug: respective disease area, important properties and SAR (structure-activity relationship), and chemical synthesis routes / options -Includes case studies in each chapter -Illustrates how chemistry, biology, pharmacokinetics, and a host of disciplines come together to produce successful medicines -Explains the advantages of process synthesis versus the synthetic route for drug discovery |
526 ## - STUDY PROGRAM INFORMATION NOTE | |
Department | Life Sciences |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drugs |
General subdivision | Design. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Pharmaceutical chemistry. |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drugs |
General subdivision | Design. |
Source of heading or term | fast |
-- | (OCoLC)fst00898790 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Pharmaceutical chemistry. |
Source of heading or term | fast |
-- | (OCoLC)fst01060115 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | MEDICAL / Pharmacology |
Source of heading or term | bisacsh |
655 #4 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Li, Jie Jack, |
Relator term | editor. |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Johnson, Douglas S. |
Fuller form of name | (Douglas Scott), |
Dates associated with a name | 1968- |
Relator term | editor. |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
Display text | Print version: |
Title | Innovative drug synthesis |
Place, publisher, and date of publication | Hoboken, New Jersey : John Wiley & Sons, 2015 |
International Standard Book Number | 9781118820056 |
Record control number | (DLC) 2015022461 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="http://dx.doi.org/10.1002/9781118819951">http://dx.doi.org/10.1002/9781118819951</a> |
Public note | Wiley Online Library |
994 ## - | |
-- | 92 |
-- | DG1 |
No items available.